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Male fertilityHuman feeding behavior and lifestyle are gradually being altered, favoring the development of metabolic dis-
eases, particularly type 2 diabetes and obesity. Leptin is produced by the adipose tissue acting as a satiety signal.
Its levels have been positively correlated with fat mass and hyperleptinemia has been proposed to negatively af-
fect male reproductive function. Nevertheless, the molecular mechanisms by which this hormone affects male
fertility remain unknown. Herein, we hypothesize that leptin acts on human Sertoli cells (hSCs), the “nurse
cells” of spermatogenesis, altering their metabolism. To test our hypothesis, hSCs were cultured without or
with leptin (5, 25 and 50 ng/mL). Leptin receptor was identiﬁed by qPCR andWestern blot. Protein levels of glu-
cose transporters (GLUT1, GLUT2 andGLUT3), phosphofructokinase, lactate dehydrogenase (LDH) andmonocar-
boxylate transporter 4 (MCT4) were determined by Western Blot. LDH activity was assessed and metabolite
production/consumption determined by proton nuclear magnetic resonance. Oxidative damage was evaluated
by assessing lipid peroxidation, protein carbonilation and nitration. Our data shows that leptin receptor is
expressed in hSCs. The concentration of leptin found in lean, healthy patients, upregulated GLUT2 protein levels
and concentrations of leptin found in lean and obese patients increased LDH activity. Of note, all leptin concen-
trations decreased hSCs acetate production illustrating a novel mechanism for this hormone action. Moreover,
our data shows that leptin does not induce or protect hSCs from oxidative damage.We report that this hormone
modulates the nutritional support of spermatogenesis, illustrating a novel mechanism that may be linked to
obesity-induced male infertility.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Human eating habits and lifestyle have been dramatically changing.
Increased consumption of energy togetherwith a sedentary lifestyle has
led to a positive energy balance. These changes contribute to anblood–testis barrier; cDNA,
enyl; FBS, fetal bovine serum;
2; GLUT3, glucose transporter 3;
nsferrin–sodium selenite; LDH,
rter 4; NT, nitro-tyrosine; Ob-R,
sphofructokinase; ROS, reactive
search Centre, Faculty of Health
ue, 6200-506 Covilhã, Portugal.increased incidence of obesity and associated metabolic diseases. Until
recently, these chronic metabolic diseases were only associated with
aging. However, this paradigm is being shifted and a growing number
of children, adolescents and young adults in reproductive age are affect-
ed by these pathological conditions [1].
Leptin, is a peptide hormone mainly produced in adipose tissue
stores [2]. It was initially called “satiety hormone”, since it was thought
to be solely produced by adipocytes of white adipose tissue, to control
energy homeostasis and decrease food intake [3]. More recently, leptin
has been reported to be also produced in other tissues [4]. The plasma
concentration of leptin tends to be increased in most obese individuals
and positively correlated with total body fat [5,6], with the exception
of the rare individuals with congenital leptin deﬁciency [7]. In fact, lep-
tin possesses anti-obesity functions, based on its ability to suppress ap-
petite and decrease body weight and adiposity [2]. Notably, leptin is
now a FDA approved [8] therapeutic for several medical conditions.
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with the speciﬁc membrane-spanning leptin (or obesity) receptor
(Ob-R) [9]. This hormone also mediates metabolic signals to the repro-
ductive system, denotingwhen sufﬁcient fat stores are available tomeet
the caloric demands of the reproductive events [10]. It has been
suggested that the hypothalamus may be the primary target for most
of leptin's actions on the reproductive axis [11]. However, based on
the characterization of leptin receptor distribution and the effects of lep-
tin on in vitro systems, direct action sites for this hormone have been
suggested both in female [12] and male reproductive tissues [13–15].
Several studies using a leptin deﬁcient rodentmodel emphasized the
role of leptin in male reproductive function. Ob/ob mice present an
autosomal-recessive mutation on chromosome 6, promoting a
profound decrease in circulating leptin levels. Among other characteris-
tics, these mice are obese and infertile [10,16]. Of note, a low-dosage
leptin treatment restored fertility in ob/ob male mice [17]. In fact,
those leptin-treated mice presented increased testicular and seminal
vesicle weight [10,16,17] and elevated sperm counts [10]. In humans,
congenital leptin deﬁciency is associated with hypogonadotropic
hypogonadism, which may be reverted upon recombinant leptin treat-
ment [18]. Yet, although it is known that leptin crosses the Sertoli–
Sertoli cell barrier (BTB) [19] and is present in the seminal plasma
[14], the molecular mechanisms by which it regulates male reproduc-
tive function remain unknown. The Sertoli cell (SC), which is the somatic
component of BTB, plays an essential role in spermatogenesis. These cells
are responsible for the physical and nutritional support of the developing
germ cells [20]. The preferential substrate of developing germ cells is lac-
tate, which is produced by the SC from several metabolic sources, partic-
ularly glucose [21]. The metabolic cooperation established between SCs
and developing germ cells is essential for the occurrence of spermatogen-
esis [20,22]. The SC metabolism is sensitive to hormonal ﬂuctuations and
presents an enormous metabolic plasticity [23]. Therefore, we hypothe-
sized that exposure to leptin can affect spermatogenesis by modulating
SCmetabolism. To test our hypothesis,weﬁrstly evaluated the expression
of the Ob-R on human SCs (hSCs). Then, hSCs were exposed to three dis-
tinct concentrations of leptin (the physiological concentration found in
lean, healthy patients and in seminal plasma; a concentration usually
detected in obese patients and a concentration found in morbidly obese
individuals). The effects on metabolite production/consumption and
protein levels and/or activity of key glucose and monocarboxylate trans-
porters and metabolic enzymes were determined. Finally, since leptin
has been suggested to alter oxidative equilibrium in cells, oxidative dam-
age in exposed hSCs was evaluated by assessing lipid peroxidation, pro-
tein carbonilation and nitration.
2. Material and methods
2.1. Chemicals
NZY M-MuLV Reverse Transcriptase, random hexamer primers,
dNTPs, NZTaq 2× Green Master Mix, agarose and DNA ladder were
obtained from NZYTech (Lisboa, Portugal). Leptin was obtained
from Bachem (Bubendorf, Switzerland). Primers were obtained
from STABVIDA (Oeiras, Portugal). All other chemicals were pur-
chased from Sigma-Aldrich (St. Louis, USA), unless stated otherwise.
2.2. Sertoli cells primary culture
Clonetics™ human SCs (MM-HSE-2305) were purchased from
Lonza (Walkersville, USA). The hSCs were thawed following the manu-
facturer protocol optimized by our group. In brief, the vial with frozen
cells was thawed at 33 °C and cells were placed in culture ﬂask with
Sertoli culture medium (1:1 mixture of DMEM-Ham's F12, pH 7.4) sup-
plemented with 15 mM HEPES, 50 U/mL penicillin, 50 mg/mL strepto-
mycin sulfate, 0.5 mg/mL fungizone, 50 μg/mL gentamicin and 10%
heat inactivated fetal bovine serum (FBS). Cells were incubated at33 °C in an atmosphere of 6% CO2. Sertoli cells cultured in the presence
of 10% FBS in F12:DMEMremainmitotically active as described [24]. The
cells used for all experiments were obtained between the third and
eighth passage to ensure reproducibility. Each “n” corresponds to a
cell passage and all experiments were performed in triplicate. After
96 h, cultures were examined by phase contrast microscopy and hSCs
culture purity was determined as described [25].
2.3. Experimental groups
Cells were allowed to grow until reach 80–85% of conﬂuence and
serum-starved before treatment. The culture medium was then re-
placed by serum-free medium (DMEM: F12 1:1, pH 7.4) supplemented
with insulin–transferrin–sodium selenite (ITSmedium; ﬁnal concentra-
tion of 10 mg/L; 5.5 mg/L; 6.7 μg/L, respectively). To evaluate the effect
of leptin on the glycolytic proﬁle of hSCs we deﬁned a control group
with ITS mediumwithout leptin and three groups supplemented leptin
(5 ng/mL, 25 ng/mL and 50 ng/mL). The concentration of 5 ng/mL was
chosen agreeing with the physiological levels found in lean, healthy
patients [26] and the concentration found in seminal plasma [14]. The
concentration of 25 ng/mL was chosen based on the levels reported in
the literature for obese patients [26].We also found relevant to evaluate
the effects of a concentration reported in morbidly obese men
(50 ng/mL) [27]. After 24 h of treatment, culturemediumwas collected.
Cells were detached, counted with a Neubauer chamber and collected.
Viability was evaluated by the Trypan Blue Exclusion test.
2.4. Cytotoxicity assay
The cytotoxicity of hSCs to leptin was determined by the colorimet-
ric sulforodamine B (SRB) assay [28]. In brief, cells were seeded and
treated with selected concentrations of leptin. After treatment, cells
were washed twice in phosphate buffered saline solution and ﬁxed
overnight in 1% acetic acid in methanol. Cells were then incubated
with 0.5% (w/v) SRB in 1% of acetic acid for 1 h at 37 °C. The unbound
dye was removed by washing with 1% acetic acid solution. Dye bound
to cell proteins was extracted with 10 mM Tris solution (pH 10) and
the optical densities of the resulting media were determined at
540 nm. No cytotoxicity was observed for the doses of leptin used in
this work (data not shown).
2.5. Reverse transcriptase polymerase chain reaction (RT-PCR)
The extraction of total RNA (tRNA) from hSCs was performed using
the E.Z.N.A. Total RNA Kit (Omega Bio-Tek, Norcross, USA) as indicated
by the manufacturer. tRNA concentration and absorbance ratios (A260/
A280) were determined by spectrophotometry (Nanophotometer™,
Implen, München, Germany). Human liver (hL) tRNA was purchased
fromAMSBiotechnology (Abingdon, UK). tRNA fromhSCs and hLwas re-
versely transcribed as described [29]. The resulting complementary de-
oxyribonucleic acid (cDNA) was used with exon-exon spanning primers
set designed to amplify Ob-R (Forward primer: TCTGGACTGCTCACGGTC
AT; Reverse primer: ACCCAGCATTTTCACGGTTTG), Sox-9 (Forward prim-
er: AGGAAGTCGGTGAAGAACGG; Reverse primer: AAGTCGATAGGGGG
CTGTCT) and GATA-4 (Forward primer: CTAGCAGCTTCTGCGCCTGT;
Reverse primer: GTGGTTCCGGAAGCTGATGTA). PCR were carried out as
described [30]. Primers' optimal annealing temperature was set to 62 °C
to Ob-R, 56 °C to Sox-9 and 58 °C to GATA-4. 35 cycles were required
for the exponential ampliﬁcation phase of fragments (180 bp to Ob-R
and GATA-4 and 275 bp to Sox-9). hL was used as positive control for
Ob-R experiments and cDNA-free sample was used as negative control.
Samples were run in 1.5% agarose gel electrophoresis (120 mV, 40 min)
and visualized using software Molecular Imager FX Pro Plus MultiImager
(BioRad, Hercules, USA) coupled to an image acquisition system (Vilber
Lourmat, Marne-la-Vallée, France). The size of the expected products
was compared to a DNA ladder.
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Western Blot was performed as described [20]. In brief, protein sam-
ples (50 μg) were fractionated on a 12% SDS-PAGE and transferred to
polyvinylidene diﬂuoride membranes. The membranes were blocked
in a Tris-buffered saline solution with 0.05% Tween 20 containing 5%
skimmed dried milk, incubated overnight at 4 °C with primary antibod-
ies and the conditions presented in Table 1. Mouse anti-β-actin was
used as protein loading control. The immune-reactive proteinswere de-
tected separately with secondary antibodies and the conditions pre-
sented in Table 1. Membranes were reacted with ECF detection system
(GE, Healthcare, Weßling, Germany) and imaged with the BioRad FX-
Pro-plus (Bio-Rad, Hemel Hempstead, UK). The densities from each
band were obtained using the Quantity One Software (Bio-Rad, Hemel
Hempstead, UK), according to standard methods.
2.7. Determination of lactate dehydrogenase (LDH) activity
LDH activity was determined using a commercial assay kit (Promega,
Madison, USA), following the manufacturer's instructions as described
[30]. The activitiesmeasuredwere calculated using themolar absorptivity
of formazan and expressed in nmol/min/mg of protein.
2.8. Measurement of oxidative damages
Protein carbonyl, nitro-tyrosine (NT) and 4-hydroxynonenal (4-HNE)
group levels were determined by Slotblot. Protein carbonyl groups were
determined as described [31]. To determine NT and 4-HNE protein levels,
2.5 μg of protein was diluted in phosphate buffer saline to a ﬁnal volume
of 100 μL and transferred to PVDFmembranes. Membranes were then in-
cubatedwith primary antibodies and the conditions presented in Table 1.
The immune-reactive proteins were detected separately with the respec-
tive secondary antibodies and the conditions presented in Table 1. Mem-
branes were reacted with ECF™ substrate (GE Healthcare,
Buckinghamshire, UK). Densities from each band were quantiﬁed using
Quantity One software (BioRad, Vilber Lourmat, France).
2.9. Proton nuclear magnetic resonance (1H NMR) spectroscopy
1H NMR spectroscopy was used to determine metabolite concentra-
tions in the extracellular media of hSCs. Fully relaxed 1H NMR spectra of
extracellular media were obtained at 14.1 T, 25 °C, using a Bruker Avance
600 MHz spectrometer equipped with a 5 mm QXI probe with a z-
gradient (Bruker Biospin, Karlsruhe, Germany) using standard methods
[32]. Sodium fumarate was used as an internal reference (6.50 ppm) to
quantify the following metabolites (multiplet, ppm): lactate (doublet,Table 1
List of antibodies used in this study.
Antibody Source Molecular weight (kDa) Dilutio
GLUT1 Rabbit 55 1:500
GLUT3 Goat 48 1:500
PFK Rabbit 85 1:400
MCT4 Rabbit 43 1:1000
LDH Rabbit 37 1:10,0
GLUT2 Rabbit 61 1:5000
β-Actin Mouse 42 1:5000
DNP Rabbit – 1:5000
4-HNE Goat – 1:5000
Nitro-Tyrosine Rabbit – 1:2500
Mouse Goat – 1:5000
Rabbit Goat – 1:5000
Goat Rabbit – 1:5000
GLUT1— glucose transporter 1; GLUT3— glucose transporter 3; PFK-1— phosphofructokinase 1
transporter 2; DNP — Dinitrophenyl; 4-HNE — 4-hydroxynonenal.1.33); alanine (doublet, 1.45); H1-α glucose (doublet, 5.22); acetate (sin-
glet, 1.9); pyruvate (singlet, 1.35). The relative areas of 1H NMR reso-
nances were quantiﬁed using the curve-ﬁtting routine supplied with
the NUTSpro NMR spectral analysis program (Acorn, Livermore, USA).
The results are expressed as consumption or production of each metabo-
lite in absolute values of pmol/cell.
2.10. Statistical analysis
Statistical differences between experimental groups were assessed by
two-way ANOVA, followed by Bonferroni's post-test. All data are shown
as mean ± SEM (n = 6 for each condition). Statistical analysis was per-
formed using GraphPad Prism 5 (GraphPad Software, San Diego, CA,
USA). p b 0.05 was considered signiﬁcant.
3. Results
3.1. Leptin receptor (Ob-R) is expressed in human Sertoli cells
Though the seller made available a speciﬁc characterization of the
cells, we further conﬁrmed that the purchased hSCs expressed speciﬁc
SCs markers (GATA-4 and Sox-9) (data not shown). The Ob-R was
previously identiﬁed in rodent testis by RT-PCR and immunohisto-
chemistry [33]. In human testis this receptor was only identiﬁed by im-
munohistochemistry [15,34]. For SCs, the Ob-R was only identiﬁed in
rodent cells by hybridization in situ [35]. Therefore, before analyzing
the effect of leptin on hSCs, we investigated the presence of Ob-R in
these cells. Using RT-PCR, we were able to detect a 180 bp amplicon
in cultured hSCs, corresponding to the presence of Ob-R mRNA (Fig. 1,
Panel A). In addition, using a speciﬁc Ob-R antibody,wewere able to de-
tect a double staining of approximately 100 kDa and 125 kDa (Fig. 1,
Panel B) corresponding to the presence of the short and long forms of
Ob-R.
3.2. GLUT2 is present in human Sertoli cells and its protein levels are increased
after exposure to a concentration of leptin found in lean men
When in culture, hSCsmetabolize glucose to lactate, which is critical
for the progression of spermatogenesis. Exposure to leptin is not able to
signiﬁcantly alter the uptake of glucose by hSCs (Fig. 2, Panel D). The
glucose enters in cells through glucose membrane transporters
(GLUTs). In hSCs, two GLUTs isoforms that participate in extracellular
glucose uptake have already been identiﬁed: GLUT1 and GLUT3 (for re-
view [20]). Exposure to leptin did not alter GLUT1 or GLUT3 protein
levels (Fig. 2, Panel A and C, respectively). Of note, wewere able to iden-
tify GLUT2 protein levels for the ﬁrst time in hSCs. Using a speciﬁcn Vendor Catalog #
Santa Cruz Biotechnology, Heidelberg, Germany sc-7903
Santa Cruz Biotechnology, Heidelberg, Germany sc-7582
Santa Cruz Biotechnology, Heidelberg, Germany sc-67028
Santa Cruz Biotechnology, Heidelberg, Germany sc-50329
00 Abcam, Cambridge, MA, USA ab52488
Santa Cruz Biotechnology, Heidelberg, Germany sc-9117
Sigma-Aldrich, Roedermark, Germany A5441
Sigma-Aldrich, Roedermark, Germany D9656
EMD Millipore, Temecula, CA, USA AB5605
Cell Signaling Technology, Danvers, MA, USA 9691S
Sigma-Aldrich, Roedermark, Germany A3562
Sigma-Aldrich, Roedermark, Germany A3687
Sigma-Aldrich, Roedermark, Germany A4187
;MCT4—monocarboxylate transporter 4; LDH— lactate dehydrogenase; GLUT2— glucose
Fig. 1. Expression of leptin receptor (Ob-R) in cultured human Sertoli cells (hSCs). Identiﬁcation of Ob-R by reverse transcriptase polymerase chain reaction (Panel A) and Western Blot
(Panel B). hL: human liver; hSCs: human Sertoli cells; and Neg: Negative control.
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61 kDa (Fig. 2, Panel B). In addition, the exposure of hSCs to the physio-
logical concentration of leptin (5 ng/mL) increased GLUT2 protein levels
to 1.13 ± 0.08 fold variation to control (Fig. 2, Panel B).
3.3. Levels of leptin reported in morbidly obese men decreased pyruvate
consumption by human Sertoli cells
Glucose is take up by hSCs through GLUTs and then metabolized.
The ﬁrst rate-limiting step in glucose metabolism is the irreversible
conversion of fructose-6-phosphate to fructose-1,6-bisphosphateFig. 2. Effect of leptin in glucose transporters and glucose consumption in human Sertoli cells (
(GLUT2) (Panel B) and glucose transporter 3 (GLUT3) (Panel C), as well as glucose consumption
Blot experiments. Panels A–C show pooled data of independent experiments, indicating the pr
pendent experiments, indicating the consumption of glucose in pmol/cell. Results are expressed
indicated: * relative to control and # relative to 5 ng/mL.by phosphofructokinase (PFK). Thus, we analyzed the protein levels of
this enzyme. Exposure to all studied leptin concentrations was not
able to alter PFK protein levels (Fig. 3, Panel A). Pyruvate consumption
by hSCs treated with leptin was found to be decreased only when
cells were exposed to a concentration reported in morbidly obese
men (Fig. 3, Panel B). One of the metabolic pathways involved in the
consumption of pyruvate, known to occur in hSCs, is its conversion to
alanine by a reversible reaction catalyzed by alanine aminotransferase.
The production of alanine was not altered when these cells were
exposed to the different concentrations of leptin used (Fig. 3, Panel
C) and closely resembled the patterns of pyruvate consumption.hSCs). Protein levels of glucose transporter 1 (GLUT1) (Panel A) and glucose transporter 2
(Panel D) by hSCs after exposure to leptin. Panels A–C also show representativeWestern
otein levels of GLUT1, GLUT2 and GLUT3, respectively. Panel D shows pooled data of inde-
asmean± SEM (n= 6 for each condition). Signiﬁcantly different results (p b 0.05) are as
Fig. 3. Effect of leptin in glycolysis of human Sertoli cells (hSCs). Protein levels of phosphofructokinase (PFK) (Panel A), as well as pyruvate consumption (Panel B) and alanine production
(Panel C) by hSCs after exposure to leptin. Panel A also show representative Western Blot experiments. Panel A shows pooled data of independent experiments, indicating the protein
levels of PFK. Panels B–C show pooled data of independent experiments, indicating the consumption of pyruvate and production of alanine in pmol/cell. Results are expressed as
mean ± SEM (n = 6 for each condition). Signiﬁcantly different results (p b 0.05) are as indicated: § relative to 25 ng/mL.
Fig. 4. Effect of leptin in lactate metabolism of human Sertoli cells (hSCs). Lactate dehydrogenase (LDH) protein levels (Panel A) and activity (Panel B), as well as, protein levels of mono-
carboxylate 4 (MCT4) (Panel C) and lactate production (Panel D) by hSCs after exposure to leptin. Panels A and C show pooled data of independent experiments, indicating the protein
levels of LDH and MCT4, respectively. Panels B and D show pooled data of independent experiments, indicating the activity of LDH or production of lactate in pmol/cell. Panels A and C
also show representativeWestern Blot experiments. Results are expressed as mean ± SEM (n= 6 for each condition). Signiﬁcantly different results (p b 0.05) are as indicated: * relative
to control; # relative to 5 ng/mL, and § relative to 25 ng/mL.
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activity
LDH is crucial for the production of lactate by SCs. LDH protein levels
were not altered in hSCs exposed to increasing doses of leptin (Fig. 4,
panel A). However, LDH activity was increased when hSCs were
exposed to leptin concentrations usually found in lean and obese men
as compared with cells in control conditions and cells exposed to a con-
centration of leptin found in morbidly obese patients. The LDH activity
increased from 0.64 ± 0.06 nmol/min/mg of protein in control condi-
tions to 1.09 ± 0.14 and 0.83 ± 0.12 nmol/min/mg of protein when
cells were exposed to 5 ng/mL and 25 ng/mL, respectively (Fig. 4,
Panel B). Furthermore, LDH activity in hSCs exposed to 5 ng/mL
(1.09 ± 0.14 nmol/min/mg) was signiﬁcantly higher than that of cells
exposed to 25 ng/mL (0.83± 0.12 nmol/min/mg). Of note, a concentra-
tion of leptin reported in morbidly obese individuals decreased LDH ac-
tivity to 0.50 ± 0.08 nmol/min/mg of protein (Fig. 4, Panel B), when
compared with cells from all other experimental conditions. Yet,
although alterations in LDH activity were observed among hSCs of the
different experimental groups, no differences were detected in the ex-
port/production of lactate by hSCs exposed to the different concentra-
tions of leptin (Fig. 4, Panel C and Panel D, respectively).3.5. Acetate production by human Sertoli cells is decreased after exposure to
leptin and no oxidative damages were detected in the cells after treatment
with leptin
SCs are known as lactate producers, however it was recently report-
ed that they also produce high amounts of acetate [22]. The production
of acetate in hSCs treated with leptin presented a decrease when
compared to control condition. The acetate production by hSCs in con-
trol condition was 1.31 ± 054 pmol/cell and 0.46 ± 0.15 pmol/cell,
0.62 ± 0.10 pmol/cell and 0.52 ± 0.15 pmol/cell in cells treated with
5 ng/mL, 25 ng/mL and 50ng/mL, respectively (Fig. 5, Panel A). Pyruvate
metabolism, particularly the lactate/alanine ratio, is linked to intracellu-
lar redox homeostasis since it reﬂects the NADH/NAD+ equilibrium
[36]. Exposure to leptin, in any of the concentrations used, does not
alter the intracellular redox state of hSCs (Fig. 5, Panel B). The high gly-
colytic rates detected in hSCs can lead to increased levels of oxidative
stress (OS). Few studies have reported that different leptin levels are as-
sociatedwith variations inOS biomarkers levels [37,38]. Protein carbon-
ylation/nitration and lipid peroxidation are excellent biomarkers of OS.
DNP, 4-HNE and NT are products formed from the attack of free radicals
to proteins and membranes. Our data showed that exposure of hSCs to
concentrations of leptin found in lean, obese and morbidly obese men,
did not alter carbonyl group (Fig. 6, Panel A), NT group (Fig. 6, Panel
B) nor 4-HNE group (Fig. 6, Panel C) levels.Fig. 5. Effect of leptin in acetate production by human Sertoli cells (hSCs) and intracellular redo
posure to leptin. Panel A shows pooled data of independent experiments, indicating the produ
indicating the lactate/alanine ratio. Results are expressed as mean ± SEM (n = 6 for each con4. Discussion
Leptin is crucial in the regulation of body glucose metabolism. Most
obese patients present a high level of leptin, which is correlated with
their adiposity [39]. Obesity has reached pandemic proportions and
the number of obese individuals is expected to dramatically increase
in the next decades. One of the negative health consequences associated
with obesity in men is reduced fertility [40]. Subfertility/infertility in
overweight and obesemen has been proposed to be due to suppression
and/or alteration of SC function [41]. One of SCs main functions is the
metabolic support of spermatogenesis (for review [20]). Since leptin is
reported to be involved in themetabolic control of reproduction (for re-
view [42]) and SCs produce the lactate needed for developing germ
cells, we hypothesized that leptin canmodulate SCsmetabolism, affect-
ing the normal occurrence of spermatogenesis and altering the fertility
potential of males. The action of leptin [43] in male reproductive func-
tion has been reported [10,17] and Ob-R was identiﬁed in rodent and
porcine testicular and epididymal tissue [13,44] and Leydig cells [35],
while there is no consensus on its presence in SC [35,44]. In humans,
the presence of the Ob-R was reported in testicular tissue [15,34]
though the authors reported lack of immunoreactivity inside the
tubules and suggested that hSCs did not express this receptor. Yet, our
results attained by PCR and conﬁrmed by Western blot, are the ﬁrst to
clearly demonstrate that Ob-R is expressed in isolated hSCs.
The SCs take glucose from circulation and produce metabolites es-
sential to sustain the development of germ cells. Although the presence
of GLUT1 has not been observed yet in human testis by immunohisto-
chemistry [45], recent studies using molecular biology techniques [20,
46,47] reported that extracellular glucose uptake by SCs is mainly
achieved by GLUT1 and GLUT3. This GLUT1/GLUT3 system is very sensi-
tive to hormonal exposure, particularly insulin [22]. GLUT2 expression
as already been identiﬁed in 42GPA9 cell line immortalized from
mouse SCs by PCR [43] and though expression of GLUT2 was suggested
to be non-detectable in human testis by immunohistochemistry [45],
we report, for the ﬁrst time, that cultured hSCs abundantly express
GLUT2, illustrating that this transporter can play a crucial role in glucose
transport. Leptin interferes with cellular glucose transport. For instance,
it is reported to decrease GLUT3 expression in the hypothalamic neuro-
nal cell line RCA6 [48]. However, in cells with high glycolytic ﬂux, such
as breast tumor cells, leptin does not alter GLUT1 expression [49]. In
hSCs, leptin does not alter GLUT1 and GLUT3 protein levels. Neverthe-
less, GLUT2 protein levels are increased after exposure to a concentra-
tion of leptin reported in the plasma of lean men [26]. However, when
hSCs were exposed to the concentration found in the plasma of obese
and morbidly obese men, no alteration was observed in GLUT2 protein
levels, relatively to control. Evidence shows that this hexose transporter
is involved in the control of food intake [50] and, in liver, leptin also up-
regulates GLUT2 levels [51]. Although the exact contribution of GLUT2x state. Acetate production (Panel A) by hSCs and lactate/alanine ratio (Panel B) after ex-
ction of acetate in pmol/cell and Panel B shows pooled data of independent experiments,
dition). Signiﬁcantly different results (p b 0.05) are as indicated: * relative to control.
Fig. 6. Induction of oxidative damages by leptin in human Sertoli cells (hSCs). Carbonyl (Panel A), nitro-tyrosine (NT) (Panel B) and 4-hydroxynonenal (4-HNE) (Panel C) group levels
measured in hSCs after exposure to leptin. Panels A, B and C showpooled data of independent experiments, indicating the expression levels of carbonyl, NT and 4-HNE, respectively. Panels
A, B and C also show representative Slotblot experiments. Results are expressed as mean ± SEM (n = 6 for each condition).
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be unveiled, the stimulation of GLUT2 protein levels by the concentra-
tion of leptin found in leanmen, illustrates a crucial mechanism depen-
dent of this hormone. However, glucose consumption by hSCs was not
altered by exposure to leptin.We have previously discussed (for review
[23]) that SCs present a high metabolic plasticity. For instance, when
cultured in insulin deprivation conditions [22], or after exposure to en-
docrine disruptors [52], these cells change the expression of glucose
transporters to sustain glucose uptake. Leptinmodulates GLUT2 protein
levels, illustrating an effect also reported in other highly metabolic sys-
tems such as liver [53]. Notably, the concentration of leptin found in
morbidly obese men induced a decrease in GLUT2 protein levels when
compared with the concentration detected in lean men providing evi-
dence that this mechanism may be relevant to obesity-related male
subfertility/infertility. Nevertheless, further studies will be needed to
test this hypothesis and disclose the relevance of this difference in
GLUT2 expression.
In SCs, the vast majority of glucose is metabolized to pyruvatewhich
is then converted to lactate. Although no changes were detected on the
protein levels of PFK or LDH, LDH activitywas stimulated by the concen-
tration of leptin detected in lean men. Notably, LDH activity decreased
by exposure to leptin in a dose-dependent manner, being progressively
smaller when hSCs were exposed to doses observed in obese and mor-
bidly obese men. This suggests that LDH activity may be a key control
point of leptin action in spermatogenesis. However, the observed
changes in GLUT2 protein levels and LDH activity did not result in alter-
ation on the production of lactate by hSCs. This illustrates that although
leptin modulates mechanisms associated to lactate production, these
cells present a metabolic plasticity that under our experimental condi-
tions allows them to sustain the production of lactate.
Although the lactate produced by SCs is referred to as the central
metabolite for spermatogenesis, these cells synthesize other metabo-
lites essential for the development of germ cells. Germ cells are con-
stantly being duplicated and their proliferation rate is quite high. hSCs
produce and export high amounts of acetate [22] that is proposed to
be essential to maintain the high rate of lipid synthesis in developing
germ cells [22], an hypothesis that was not yet tested but likely to
occur. Leptin affects lipid catabolism in human placenta [54] and
promotes the synthesis of acyl-coenzyme A, a pivotal intermediate in
fatty acids metabolism, during monocyte-macrophage differentiation
[55]. Moreover, it is reported that acetate may have an inhibitory effect
on leptin secretion in epididymal adipocytes [56]. As referred, during
spermatogenesis, there is a high rate of lipid synthesis and remodeling
[57] and acetate is known to be the most reliable carbon source for
lipid synthesis [58]. Acetate production by SCs is very sensitive to hor-
monal treatment, particularly insulin [22] and melatonin [59]. Ourresults show that acetate production by hSCs is severely decreased
after exposure to all concentrations of leptin. This is consistent with
reports showing that leptin decreases acetate degradation in isolated
adipocytes and its incorporation into lipids [60]. In fact, leptin directly
suppresses some biochemical pathways in peripheral tissues and cells,
particularly those involving acetyl-CoA carboxylase [61]. Since all leptin
concentrations, including the concentration found in lean men, altered
acetate production by hSCs, further studies are needed to explore
the hypothesis that this is a relevant mechanism for obesity-related
subfertility/infertility by having a synergistic action with other hor-
mones and factors.
Though absolute differences in metabolites concentration detected
are due to exposure to leptin and thus reveal the direct action of this
hormone in hSCs, wemust highlight that absolute quantiﬁcations differ
from our previous reports [22,62,63]. This difference in absolute quanti-
ﬁcation is due to several factors, particularly those that might not allow
a simple comparison: the ITS supplement is very different; the stoichio-
metric pressure over some pathways, instead of other is very distinct;
and this studywas done after 24 h of culture while the others were per-
formed at least in 48 h. Moreover, the hSCs used were purchased and
only then expanded while our previous studies were done using hSCs
isolated from fresh biopsies. The results attained allowed us to assess
the effect of leptin in hSCs.
Compelling evidence suggests that leptin's action induces oxidative
stress (OS) and reactive oxygen species (ROS)may serve as secondmes-
sengers in leptin-mediated signaling. Moreover, it has been reported
that leptin induces OS in human endothelial cells (10 ng/ml) [64] and
plasma of Wistar rats [65]. The cellular glucose sensing machinery and
cell metabolism are closely related to OS, particularly the lactate/alanine
ratio [29]. Indeed, this ratio is an index of cellular redox state [66]. The
higher is the NADH level in the cytosol, the more extensive is the con-
version of pyruvate to lactate by LDH, and such leads to a considerable
reduction of the alanine pools through the action of alanine transami-
nase. Of note, when exposed to some compounds such as the antidia-
betic metformin [30], SCs adapt their metabolic behavior to maintain
the NADH/NAD+ equilibrium. Interesting, in hSCs, the intracellular
redox equilibrium remains unaltered after exposure to leptin. More-
over, the group levels of carbonyl, NT and 4-HNE were not altered
after hSCs were exposed to leptin, illustrating that this hormone does
not promote oxidative damage in these cells even at concentration
found in morbidly obese men.
Obesity and its associated co-morbidities have reached pandemic
proportions. Men suffering with those diseases have fertility problems
that end-up in subfertility and infertility. Among the several hormonal
andmetabolic alterations caused by the expansion of fatmass, increased
leptin levels is a well-known characteristic of these individuals. Leptin
1831A.D. Martins et al. / Biochimica et Biophysica Acta 1852 (2015) 1824–1832acts in several tissues and cellular systems altering their metabolic be-
havior. For instance, leptin was reported to stimulate the metabolic ac-
tivity of NK-92 cells, which belong to the innate immune system and
mediate several anti-tumor responses [67]. Besides, hyperleptinemia
is associated with carcinogenesis [68], which is known to be related
with an increased glycolytic proﬁle of cells [69]. Within the testis, the
glycolytic activity of SCs is pivotal to the normal occurrence of sper-
matogenesis. Herein we report that Ob-R mRNA and protein are
expressed in hSCs and that leptin directly acts on these cells modulating
their metabolic behavior. Leptin stimulates GLUT2 protein levels and
LDH activity, and severely decreases the production of acetate by hSCs.
This is a ﬁrst assessment of how leptin can interfere with the metabolic
support of spermatogenesis by hSCs. Further studies will be needed to
fully disclose the role of leptin in Sertoli-germ cells interaction and its
relevance for male fertility.
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